Naptumomab estafenatox
From Wikipedia, the free encyclopedia
|
Naptumomab estafenatox?
|
|
| Therapeutic monoclonal antibody | |
| Source | Mouse |
| Target | 5T4 Fab |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C3255H5025N855O1050S18 |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Naptumomab estafenatox is a monoclonal antibody and which it is used to treat cancers. It has a chelator, estafenatox. It binds to 5T4 Fab.
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
